Therapeutic Medical Cannabis Studies

A

• addiction (10)

• alzheimers/dementia (14)

• amyotrophic-lateral-sclerosis-als-lou-gehrigs (2)

• antibacterial (6)

• antioxidant (8)

• antiprion (1)

• anxiety (10)

• appetite (4)

• arthritis (4)

• attention-deficit-hyperactivity-disorder-adhd (5)

• autism (11)

• autoimmune (3)

B

• batten-disease (6)

• benefits (9)

• breast-cancer (7)

C

• cancer (94)

• cannabidiol-cbd (8)

• cardiovascular (8)

• cb1-receptor (8)

• cb2-receptor (9)

• cellular-function (4)

• cerebral-palsy (1)

• cognition (2)

• colon-cancer (8)

D

• d9-tetrahydrocannabinol-thc (4)

• d9-tetrahydrocannabinolic-acid-thca (1)

• diabetes (4)

• drug-interactions (2)

E

• endocannabinoid-system-ecs (45)

• endocrine-system (3)

• epilepsy (30)

F

• fibromyalgia (2)

• fibrosis (1)

G

• gastrointestinal-disease (6)

• general (20)

• glaucoma (1)

• glioblastoma (1)

H

• health-care (1)

• huntingtons-disease (1)

I

• immune-function (8)

• infant-development (1)

• inflammation (9)

• ischemia (3)

K

• krabbe-disease (4)

L

• lung-cancer (2)

M

• mental-illness (14)

• migraine (1)

• mitochondria (1)

• multiple-sclerosis (15)

N

• national-institute-on-drug-abuse-nida (1)

• nervous-system (4)

• neuro-protective-and-neuro-generative (7)

P

• pancreatitis (1)

• prostate-cancer (2)

S

• schizophrenia (2)

T

• therapeutic (1)

• traumatic-brain-injury-tbi (1)

• View All (505)

A National Needs Assessment of Canadian Nurse Practitioners Regarding Cannabis for Therapeutic Purposes. (2018)

In Canada, the Cannabis Access Regulation for Medical Purposes (ACMPR) has granted practicing nurses (NPs) the power to authorize cannabis for therapeutic purposes (CTP) to eligible patients. This national study was focused to assess NPs�knowledge and practice gaps related to CTP to inform the development of future education resources that increase NPs’ clinical competence and improve patient care related to medical cannabis. View study